inspiring medical recruitment Home: only medics - inspiring medical recruitment
Home About Us Clients Candidates Vacancies Training Resources Contact Us


Resources Home
Health News
Articles
Downloads
Links
Medical Dictionary
Pharmaceutical Terms

Resources

articles recently published on topics of medical interest

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

01/06/2010

Colorectal cancer is the third most common cancer worldwide and has a high mortality rate. We tested the hypothesis that only one flexible sigmoidoscopy screening between 55 and 64 years of age can substantially reduce colorectal cancer incidence and mortality.

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis

03/05/2010

No clinical trials have assessed the effects or cost-effectiveness of sequential screening strategies to detect new cases of type 2 diabetes. We used a mathematical model to estimate the cost-effectiveness of several screening strategies.

Survival as a function of HbA1c in people with type 2 diabetes:
a retrospective cohort study

11/04/2010

Results of intervention studies in patients with type 2 diabetes have led to concerns about the safety of aiming for normal blood glucose concentrations. We assessed survival as a function of HbA1c in people with type 2 diabetes.

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

09/03/2009

The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive therapy with benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing cardiovascular morbidity and mortality. We assessed the effects of these drug combinations on progression of chronic kidney disease.

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

15/02/2010

Variation in and irreversibility of platelet inhibition with clopidogrel has led to controversy about its optimum dose and timing of administration in patients with acute coronary syndromes. We compared ticagrelor, a more potent reversible P2Y12 inhibitor with clopidogrel in such patients.

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21/12/2009

Associations of C-reactive protein (CRP) concentration with risk of major diseases can best be assessed by long-term prospective follow-up of large numbers of people. We assessed the associations of CRP concentration with risk of vascular and non-vascular outcomes under different circumstances.

Stroke treatment with alteplase given 3•0—4•5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial

22/10/2009

In the European Cooperative Acute Stroke Study III (ECASS III), alteplase administered 3•0—4•5 h after the onset of stroke symptoms resulted in a significant benefit in the primary endpoint (modified Rankin scale [mRS] score 0—1) versus placebo, with no difference in mortality between the treatment groups. Compared with the 0—3 h window, there was no excess risk of symptomatic intracranial haemorrhage. We assessed the usefulness of additional endpoints and did subgroup and sensitivity analyses to further investigate the benefit of alteplase.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

19/08/2009

Proton-pump inhibitors (PPIs) are often prescribed in combination with thienopyridines. Conflicting data exist as to whether PPIs diminish the efficacy of clopidogrel. We assessed the association between PPI use, measures of platelet function, and clinical outcomes for patients treated with clopidogrel or prasugrel.

Randomised controlled trial of a secondary prevention program for myocardial infarction patients.

18/05/2009

Coronary heart disease (CHD) is a significant cause of health and economic burden. Secondary prevention programs play a pivotal role in the treatment and management of those affected by CHD although participation rates are poor due to patient, provider, health system and societal-level barriers. As such, there is a need to develop innovative secondary prevention programs to address the treatment gap. Telephone-delivered care is convenient, flexible and has been shown to improve behavioural and clinical outcomes following myocardial infarction (MI). This paper presents the design of a randomised controlled trial to evaluate the efficacy of a six-month telephone-delivered secondary prevention program for MI patients (ProActive Heart).

Thymostimulin in advanced hepatocellular carcinoma a phase II trial

13/03/2008

Thymostimulin is a thymic peptide fraction with immune-mediated cytotoxicity against hepatocellular carcinoma in vitro. This phase II trial investigated safety and efficacy including selection criteria for best response in advanced or metastasised hepatocellular carcinoma.

Multidrug-resistant tuberculosis

25/02/2008

With almost 9 million new cases each year, tuberculosis remains one of the most feared diseases on the planet. Led by the STOP-TB Partnership and WHO, recent efforts to combat the disease have made considerable progress in a number of countries. However, the emergence of mutated strains of Mycobacterium tuberculosis that are resistant to the major anti-tuberculosis drugs poses a deadly threat to control efforts.

Persistence of the immune response induced by BCG vaccination

25/02/2008

Although BCG vaccination is recommended in most countries of the world, little is known of the persistence of BCG-induced immune responses. As novel TB vaccines may be given to boost the immunity induced by neonatal BCG vaccination, evidence concerning the persistence of the BCG vaccine-induced response would help inform decisions about when such boosting would be most effective.

A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease

25/02/2008

Cardiovascular events are the leading cause of death in end stage renal disease (ESRD). Adherence to phosphate binding medication plays a vital role in reducing serum phosphorus and associated cardiovascular risk.

Evaluating dose response from flexible dose clinical trials

25/02/2008

The true dose effect in flexible-dose clinical trials may be obscured and even reversed because dose and outcome are related.

Predictability and epidemic pathways in global outbreaks of infectious diseases

25/02/2008

The SARS epidemic has clearly shown the importance of considering long-range transportation networks in understanding emerging diseases outbreaks. The introduction of extensive transportation data sets is an important step in order to develop epidemic models endowed with realism.

Impact of delayed initiation of erythropoietin in critically ill patients

02/11/2007

The purpose of this study was to evaluate the impact of recombinant human erythropoietin (rHuEPO) use for anemia of critical illness at a practice site where delayed initiation is common.

Insulin and its role in cancer

02/11/2007

Studies have shown that metabolic syndrome and its consequent biochemical derangements in the various phases of diabetes may contribute to carcinogenesis. A part of this
carcinogenic effect could be attributed to hyperinsulinism.

The influence of gender on the effects of aspirin in preventing myocardial infarction

02/11/2007

There is considerable variation in the effect of aspirin therapy reducing the risk of myocardial infarction (MI). Gender could be a potential explanatory factor for the variability.

A guide to modern statistical analysis of immunological data

02/11/2007

The number of subjects that can be recruited in immunological studies and the number of immunological parameters that can be measured has increased rapidly over the past decade and is likely to continue to expand.

Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil

02/11/2007

Polysaccharide pneumococcal vaccine is recommended for use in HIV-infected adults in Brazil but there is uncertainty about its effectiveness in this patient population.

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy

02/11/2007

Prognostic factors in locally advanced breast cancer treated with neoadjuvant chemotherapy differ from those of early breast cancer. The purpose of this study was to identify the clinical significance of potential predictive and prognostic factors in breast cancer patients treated by neoadjuvant chemotherapy.

Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors

02/11/2007

Aberrant promoter hypermethylation of cancer-associated genes occurs frequently during carcinogenesis and may serve as a cancer biomarker. In this study we aimed at defining a quantitative gene promoter methylation panel that might identify the most prevalent types of renal cell tumors.

Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines

02/11/2007

Despite numerous studies aimed at verifying the antitumor activity of nitric oxide-releasing nonsteroidal antiflammatory drugs (NO-NSAIDs), little is known about the molecular targets

Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study

02/11/2007

The objective of the present study was to evaluate if an e-mail with a drug information attachment has effects on sales of prescribed drugs and if the design of the attachment is of importance.

Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005

02/11/2007

Adverse drug reactions (ADRs) are a frequent cause of mortality and morbidity to patients worldwide, with great associated costs to the healthcare providers including the NHS in England.


©2009 only medics ltd

Home | Privacy Policy | Site Map